Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT06504576
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Registry
-
NCT06504576
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Recruiting
Technical summary
Registry record NCT06504576. Randomized; no masking; primary purpose treatment. Start 2025-06-16 (actual); primary completion 2027-01-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage
- Acronym
- EPOCH
- Condition
- ICH - Intracerebral Hemorrhage
- Intervention (Drug)
- Pletaal 100mg/tab
- Intervention (Procedure)
- Conventional internal medicine treatment
- Lead sponsor
- National Taiwan University Hospital
Record details
- Record id
cardio:ct-nct06504576- Content hash
263580eaa347853415298fc30b1e10f29fcb19175c4dfe40756415364a97c3e5